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Summary
Reconsolidation is a putative neuronal process in
which the retrieval of a previously consolidated mem-
ory returns it to a labile state that is once again subject
to stabilization. This study explored the idea that re-
consolidation occurs in spatial memory when animals
retrieve memory under circumstances in which new
memory encoding is likely to occur. Control studies
confirmed that intrahippocampal infusions of aniso-
mycin inhibited protein synthesis locally and that the
spatial training protocols we used are subject to over-
night protein synthesis-dependent consolidation. We
then compared the impact of anisomycin in two condi-
tions: when memory retrieval occurred in a reference
memory task after performance had reached asymp-
tote over several days; and after a comparable extent
of trainingofadelayedmatching-to-place task inwhich
new memory encoding was required each day. Sensi-
tivity to intrahippocampal anisomycin was observed
only in the protocol involving new memory encoding
at the time of retrieval.
Introduction
The purpose of this study was to examine the generality
of the concept of memory ‘‘reconsolidation’’ (Misanin
et al., 1968; Nader et al., 2000; Przybyslawski and Sara,
1997). Memory consolidation refers to the progressive
postacquisition stabilization of a memory item and to
the temporal phase when this stabilization takes place.
The classic consolidation hypothesis (Dudai and Morris,
2001; McGaugh, 1966; Muller and Pilzecker, 1900) postu-
lates that consolidation starts and ends just once for
each item in long-term memory. In contrast, the reconso-
lidation hypothesis holds that items in long-term mem-
ory can re-enter a consolidation phase when reactivated.
Upon reactivation, the stabilized memory item transiently
destabilizes and again engages neuronal mechanisms
of restabilization. Accordingly, memory reactivation be-
*Correspondence: r.g.m.morris@ed.ac.ukcomes susceptible to amnesic agents, such as protein
synthesis inhibitors.
The notion of reconsolidation has been with us since
the 1960s (Misanin et al., 1968) but has recently been re-
vitalized by a series of experiments, triggered mostly by
the studies of Nader et al. (2000) on fear conditioning
in the rat. These authors reported that postretrieval
infusions into the lateral amygdala of the protein synthe-
sis inhibitor anisomycin, a widely used consolidation
blocker, disrupted the subsequent retrieval of rapidly
acquired fear memory. Anisomycin in the absence of
memory reactivation had no effect. The amnesic effect
of postretrieval anisomycin infusion was long lasting. In
additional studies from the same group, hippocampal
lesions disrupted contextual fear conditioning when
given 45 days after training, again providing that the
memory was reactivated shortly before the lesion was
made (Debiec et al., 2002). Reconsolidation has also
been reported in other memory paradigms and in spe-
cies ranging from molluscs and bees to humans (Dudai
and Eisenberg, 2004; Nader, 2003; Sara, 2000b).
Despite the growing number of reports that support
the reconsolidation hypothesis, alternative interpreta-
tions have been raised to account for the postreactiva-
tion effects of amnesic agents. One suggestion is that
reconsolidation is a lingering consolidation process as-
sociated with the original training (Alberini, 2005; Dudai,
2004). According to this view, consolidation may stop
temporarily and then be restarted by memory reactiva-
tion, with some differences in the underlying neural
mechanisms associated with training- and reactiva-
tion-associated forms of consolidation. Another possi-
bility is that behavioral phenomena that may appear to
indicate a ‘‘reconsolidation’’ process might actually re-
flect a reactivation-locked, temporary inability to access
memory traces that dissipates over time (Lattal and
Abel, 2004). A third possibility is that apparent amnesia
is the consequence of blocking a retrieval-associated
updating process that is required to keep old memories
useful and retrievable (Dudai and Eisenberg, 2004). It
is also becoming clear that reconsolidation is not a uni-
versal feature of memory retrieval, rendering the identifi-
cation of its generality and boundary conditions all the
more important (Eisenberg et al., 2003; Nader et al.,
2005; Pedreira and Maldonado, 2003).
Relatively few recent studies have investigated recon-
solidation in relation to allocentric spatial memory (e.g.,
Przybyslawski and Sara, 1997; Suzuki et al., 2004). Spa-
tial memory is rapidly acquired, like fear conditioning
and inhibitory avoidance (Milekic and Alberini, 2002;
Nader et al., 2000), but certain training protocols can re-
sult in performance reaching an asymptote at which
point no new memory encoding needs to occur because
the spatial environment is adequately represented in
memory for the task in hand. We hypothesized that
this would be a point at which retrieval-associated re-
consolidation would no longer be required unless, due
to changes in the environment, new memory encoding
was engaged. In other spatial learning protocols, the
state of the environment may be changing all the time,
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480Figure 1. Experimental Design
The series of procedures for the six experiments are depicted, together with intervals of time between training stages. Bilateral intrahippocampal
drug infusions are depicted as syringe cartoons of two types. Open syringes are aCSF infusions; shaded syringes refer to either aCSF or aniso-
mycin infusions across groups. Reactivation trials, extinction trials, and test probes were all procedurally identical but are named in relation to
their distinct purpose within each study. Means 6 1 SEM.with the brain systems responsible for representing allo-
centric space attempting to keep track of altered rela-
tionships. Under these circumstances, memory encod-
ing will remain engaged at the time of retrieval, with
the memory representations that have been subject to
consolidation being rendered labile and, as a conse-
quence, subject to reconsolidation. Securing positive
findings of a differential effect of intrahippocampal ani-
somycin would establish boundary conditions that favor
reconsolidation of spatial memory in a theoretically co-
gent framework using an intervention that acts in a re-
gionally specific manner.
Results
To investigate whether a reconsolidation process is
specifically engaged when the act of retrieval of spatial
memory is, or is likely to be, associated with new mem-
ory encoding, we compared two distinct hippocampus-
dependent water maze tasks. Only one of these tasks
was likely to involve new memory encoding in associa-
tion with retrieval at the equivalent point in training on
each when reconsolidation was being investigated.
The design of our training protocols was predicated on
the capacity of the paradigms that have been used to
date to reveal reconsolidation, coupled with the desire
to calibrate any findings against effects upon consolida-
tion and/or the extinction of spatial learning (Abel and
Lattal, 2001; Lattal and Abel, 2004). We began by devel-
oping a single training protocol in the water maze (Fig-
ure 1) that could be used to study consolidation (experi-ment 1), reconsolidation (experiment 2), and nonspecific
drug effects (experiment 3). This used the ‘‘on-demand’’
(Panakhova et al., 1984) or Atlantis Platform (Spooner
et al., 1994) procedure in the first training trial of each
day to monitor memory retrieval unaffected by new
learning or reminding. In this procedure, the escape plat-
form only becomes available after 60 s of trial 1 on each
day, allowing that trial to serve as a reinforced memory
probe trial during training and post-memory reactivation
treatments. A change in the behavioral training protocol
to a delayed matching-to-place (DMP) procedure was
then introduced for experiments 4 and 5, with the extent
of overall training kept equivalent. The relevant feature of
DMP is that, irrespective of the extent of training, new
memory encoding is required each day as the location
of the escape platform changes. Importantly, the same
extent of training (6 days) was used in both the reference
memory and DMP experiments. Finally (experiment 6),
we examined the impact of intrahippocampal anisomy-
cin on extinction. Separate autoradiographic measure-
ments of the uptake and incorporation of [14C]L-leucine
were also made to establish that anisomycin was suc-
cessful in inhibiting protein synthesis locally when in-
fused into the dorsal hippocampus.
Blockade of Protein Synthesis in the Dorsal
Hippocampus
Autoradiographic imaging and quantitative densitomet-
ric analysis of [14C]L-leucine uptake into the brain en-
abled the extent and spatial distribution of the inhibition
of protein synthesis to be visualized and quantified.
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bral anisomycin are shown in Figure 2. Close to the injec-
tion site, at the septal pole of the dorsal hippocampus
(Paxinos and Watson, 1998), protein synthesis inhibition
was well localized at the infusion site (Figure 2A). Inhibi-
tion in parts of the contralateral hippocampus was seen
in three out of the six animals, but this is unimportant
in the context of the bilateral infusions of anisomycin
Figure 2. Protein Synthesis Analysis and Consolidation of Spatial
Reference Memory—Experiment 1
Autoradiographic images of [14C]L-leucine localization reflect
greater signal density over the cell bodies of hippocampal subfields
in the absence of anisomycin. Representative brain sections were
chosen to reflect the following: (A) Localized inhibition of protein
synthesis in the dorsal hippocampus at the site of infusion on the
left of the image (white regions). (B) In the same animal as (A), the
limit of this inhibition, with near normal protein synthesis in the pos-
terior and ventral hippocampus. (C) In a different animal, the maxi-
mal extent of neocortical involvement around the injection site.
(D) In the consolidation control study, the time spent in the target
quadrant during the first trial of each session’s training is plotted
for retrieval tests 1–6, the memory reactivation trial (test 7), and
the postreactivation memory test (test 8). Drug infusions are given
after each training session. Note that anisomycin-treated rats failed
to show overnight memory of the location of the platform (chance =
25%). (E) First crossing latency (s) for the four trials of each session
averaged across sessions 1–6. Animals treated with anisomycin af-
ter each session are capable of learning and show a striking reduc-
tion in latency between training trials 1 and 2. (F) The proportion of
time spent in the target quadrant during new learning in the second
context (water maze 2). No drug infusions are given. The previous
anisomycin-treated animals can learn, catch up the previous aCSF
group, and show equivalent levels of performance during retrieval
tests 5 and 6. Means 6 1 SEM.used in the behaviorally trained animals. At a more pos-
terior and temporal location of the longitudinal axis, the
area of inhibition was more circumscribed, with much of
the ventral hippocampus unaffected (Figure 2B). There
was some evidence of inhibition in extrahippocampal re-
gions—including overlying neocortex. Figure 2C shows
the animal in which this was most marked. However,
there also appeared to be leakage of anisomycin from
the injection site into the ventricular system, and in all an-
imals, there were some indications of partial inhibition
in periventricular tissues, such as hypothalamus (Figures
2A and 2C) and periaquaductal gray matter (Figure 2B).
The patterns of inhibition found in contralateral hippo-
campus suggest that here too anisomycin gained access
via the ventricular system, rather than spreading by bulk
flow.
Quantification of the autoradiographic images (Table
1) shows that the uptake and incorporation of [14C]L-leu-
cine was substantially reduced in hippocampal cell pop-
ulations close to the injection of anisomycin. In dorsal
CA1, for example, tissue tracer concentrations were re-
duced from a mean of 98 nCi.g21 on the aCSF-injected
side to 6 nCi.g21 on the anisomycin-injected side, a re-
duction of 94%. In the septal pole of the hippocampus
as a whole, tracer levels were reduced by 97%. Given
that residual levels of tracer in trunk blood remained
quite high at the time of sacrifice (93 6 2 nCi/ml), the
contribution of the blood compartment in brain to the
total tissue concentrations will prevent the measured
values ever reaching zero. Thus, the primary site of ac-
tion was the dorsal and middle regions of the hippocam-
pal formation.
Histological Analysis
All behaviorally trained rats were sacrificed at the end of
the experiment, and the brains were carefully removed
from the skull and associated ‘‘headcap’’ containing
the cannulae. Once stained, brain sections were care-
fully examined for tissue damage. The tips of bilateral
cannulae were found to be located in the dorsal hippo-
campus of all rats reported above, with minimal tissue
damage affecting the target structure. All animals
Table 1. Uptake of [14C]L-leucine into Hippocampus following
Local Infusion of Anisomycin or aCSF
Hippocampal Area
Tracer Concentration (nCi/g)
Percentage
ChangeaCSF Anisomycin
Septal (Dorsal)
CA1 98 6 18 6 6 4* 294
CA2 113 6 6 5 6 2* 296
CA3 116 6 17 5 6 2* 296
Dentate 145 6 20 9 6 5* 294
Total hippocampus 123 6 13 4 6 3* 297
Temporal (Ventral)
Subiculum 70 6 15 18 6 12* 274
CA1 99 6 6 108 6 16 +9
CA2 102 6 6 109 6 10 +6
CA3 133 6 15 128 6 18 24
Dentate 125 6 20 64 6 48* 249
Total hippocampus 110 6 16 91 6 16 217
Data are presented as mean6SD (n = 6 in each group). *Significantly
different from hippocampus injected with aCSF (p < 0.05, paired
t-test).
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ence Memory and Infusion-Only Control—
Experiments 2 and 3
(A) Time spent in the target quadrant during
training, memory reactivation, and the re-
trieval test and 1 week test trials. The drug
infusions occurred immediately after retrieval
test 7 (memory reactivation). Anisomycin
failed to disrupt memory tested on session 8.
(B) In the infusion-only control task, drug infu-
sions occurred on session 7, but exposure to
the water maze was omitted. There was no
change in performance in retrieval test 8
from that observed at the end of training, re-
flecting the omission of the memory reactiva-
tion/extinction trial.
Means 6 1 SEM.infused with aCSF were rated as having brain damage
scoring 0 or 1 (see Experimental Procedures for the scor-
ing system). Three anisomycin-treated animals were
rated as having scores of 2 or more in experiment 1,
and one animal with a score of 3 was excluded from
the data analysis, with the threshold for inclusion set at
unilateral damage only. Five anisomycin animals were
rated as having a score of 2 in experiment 2, and all
were included in the analysis. In experiment 4, two aniso-
mycin animals were rated as having scores of 3 or above
and were excluded from the data analysis. The group
numbers in each of the studies are of animals included
after histological assessment.
Consolidation of Reference Memory Is Impaired
by Anisomycin—Experiment 1
As both experiments 2 and 4 (below) used four trials
of training per day, a control study was conducted to
confirm that daily post-training injections of anisomycin
into the dorsal hippocampus would preclude the consol-
idation of spatial memory trained in this way. Impaired
overnight memory consolidation was revealed in an anal-
ysis of the proportion of time spent in the correct quad-
rant of the water maze during the daily probe tests
(Figure 2D). Over days 1–6, the ANOVA showed no overall
difference between groups (F = 3.55, df 1/13, p = 0.08),
a significant improvement across successive retrieval
tests (F = 9.36, df 5/65, p < 0.001) and, critically, a highly
significant groups 3 retrieval tests interaction (F = 5.05,
df 5/65, p < 0.001). A separate analysis was conducted
of performance in the memory reactivation and post-
reactivation memory tests (sessions 7 and 8), revealing
an impairment in the anisomycin-treated group (F =
8.27, df 1/13, p < 0.025). All analyses were also con-
ducted using the measure introduced by Moser et al.
(1995) of time spent in a 40 cm diameter zone around
the correct location; these revealed an identical pattern
of statistically significant effects (data not shown).
Within-session learning (averaged across all six train-
ing sessions) indicated that the anisomycin group took
longer to cross the correct location of the platform on
trial 1 but nonetheless showed effective within-session
learning (Figure 2E). The ANOVA revealed a decline in
latency across the four daily trials (F = 35.23, df 3/39,
p < 0.001) and a significant groups 3 trials interaction
(F = 3.35, df 3/39, p < 0.05). There was a significant dif-
ference between groups on trial 1 (F = 6.16, df 1/14,
p < 0.05), pointing to overnight forgetting in the anisomy-cin-treated animals as indexed by time to reach the
platform.
Training in WM2 without drug infusions revealed suc-
cessful learning by the group previously treated with
anisomycin (Figure 2F). Both groups showed a steady
improvement in memory retrieval across the four probe
trials (F = 15.54, df 3/39, p < 0.001). The groups did not
differ on sessions 5 and 6 of the new learning phase
(F < 1). The modest trend reflecting apparently faster
learning by the group previously given aCSF (F = 3.41,
df 1/13, p > 0.05) most likely reflects the benefit of the an-
imals’ successful earlier training in WM1 rather than any
(nonsignificant) deficit in the anisomycin group. Indeed,
a comparison of performance on session 4 of the new
learning protocol (Figure 2F) with session 4 of training
in the initial spatial training period (Figure 2D) confirms
that the animals previously treated with anisomycin
were now learning at a similar rate to the aCSF group
during initial training (percent time in target quadrant:
aCSF = 44.1% 6 3.9%; Ani = 47.5% 6 9.6%). Thus, the
group previously treated with anisomycin could learn
a spatial location in a new environment normally; i.e., it
displayed no lasting functional deficit, a ‘‘behavioral his-
tology’’ finding compatible with the exacting selection
of animals based on true histological criteria. A deficit
might have been seen had animals with partial brain
damage been included, and the failure to use such ex-
acting histological criteria could, in turn, have compro-
mised the interpretation of experiments 2 and 4 below.
Retrieval of Asymptotic Spatial Reference Memory Is
Unaffected by Anisomycin—Experiment 2
Figure 3A shows performance in the daily probe tests
(trial 1 of each day). The groups did not differ during
training (Fs < 1) and showed equivalent excellent search
performance during the memory reactivation trial of ses-
sion 7 (72 hr after session 6). In absolute terms, the pro-
portion of time spent in the target quadrant during the
retrieval test of session 7 (57.78% 6 3.29% averaged
across groups) was equivalent to that obtained by the
aCSF group in experiment 1 (61.06% 6 6.8%).
Bilateral intrahippocampal infusion of anisomycin
following the memory reactivation trial of session 7 did
not result in poorer performance in the postreactivation
test probe the next day (F < 1). Performance declined
between sessions 7 and 8 (F = 15.62, df 1/27, p <
0.001), reflecting extinction, but this decline did not differ
across groups (F = 1.90, df 1/27, p > 0.10; performance in
Reconsolidation of Spatial Memory
483Figure 4. Reconsolidation of 1 Day Memory
(DMP) and Infusion-Only Control—Experi-
ments 4 and 5
(A) Time spent in the target zone during train-
ing (sessions 1–6), the memory reactivation,
and test probe trials. The drug infusions oc-
curred immediately after probe test 7 (mem-
ory reactivation) scheduled 72 hr after ses-
sion 6 (as in experiment 2). Anisomycin
caused a clear disruption of memory to
chance level (4%) when tested 1 day later.
(B) The subset of animals that individually
showed effective memory (twice chance
level) during retrieval test 7. The decline to
chance in test 8 is confirmed.
(C) In the infusion-only control, which could be run within-subjects for the DMP task, drug infusions occurred on session 4, but exposure to the
water maze was omitted. There was no effect of anisomycin in the absence of memory reactivation.
Means 6 1 SEM.retrieval test 8: aCSF = 46.9% 6 5.4%; ANIS = 44.6% 6
4.2%). While there was a trend for the decline to be
greater in the anisomycin group, it did not approach sig-
nificance, despite the large group sizes. When tested
again 1 week after the reactivation trial, the two groups
again did not differ (F < 1).
Anisomycin Infusion without Memory Reactivation
Also Has No Effect on Spatial Reference Memory—
Experiment 3
Experiment 3 was conducted to examine the nonspe-
cific effects of intrahippocampal infusions of anisomycin
on long-term spatial memory. Figure 3B shows that nei-
ther group differed during the 6 days of training with
respect to time spent in the target quadrant (F < 1). An
ANOVA revealed no difference between groups across
retrieval sessions 8 and 9 (F < 1) and, despite an appar-
ent trend in the 1 week test, no interaction across ses-
sions. Importantly, performance in probe test 8 showed
no decline from the end of training.
Retrieval of 1 Day Spatial Memory Is Impaired
by Anisomycin—Experiment 4
In the DMP task, the animals learn a platform location
during the four daily trials and a new location on each
of the days thereafter for as long as training continues.
An effective strategy is acquired across days, in which
the rats show a small but highly significant tendency to
search in the previous session’s platform location on
the first trial of each day (retrieval) and immediately after
encoding information about the new platform location
(Steele and Morris, 1999). Accordingly, memory retrieval
reaches an above chance asymptotic mean that remains
relatively stable across days (Figure 4A). In a target zone
of 40 cm diameter centered on the varying locations
of the escape platform in a 1 meter radius pool, the ratio
of surface areas is 25:1, leading to a chance level of 2.5 s
spent searching in the target zone (i.e., 4%; chance may
actually be slightly higher, as the animals quickly de-
velop a tendency to search away from the side walls,
and the area ratio calculation underestimates this). Tar-
get search rises from 4% to 6% to a relatively stable
mean of 10% to 14% across days 1 to 6, reflecting mod-
est but significant memory (ANOVA: days F = 3.80,
df 3.8/64.6 p < 0.01; Greenhouse-Geisser correction)
with no difference between groups as a function of their
subsequent drug treatment (F < 1).The critical comparison is the change in performance
between sessions 7 and 8, each consisting of a memory
retrieval trial without the possibility of escape onto the
platform (Figure 4A). The ANOVA showed a significant
decline between these sessions (F = 7.24, df 1/17, p <
0.025) and that the groups did not differ on session 7
(conducted 72 hr after session 6 as in experiment 2; F <
1) but did differ on session 8 (F = 9.56, df 1/17, p < 0.01).
The group treated with anisomycin after memory re-
trieval on session 7 showed apparently complete forget-
ting in retrieval test 8. Relative to the estimated chance
level, both groups showed above chance memory on
session 7 (ps < 0.05), but only the aCSF group was above
chance on session 8 (p < 0.01). This pattern is consistent
with a reconsolidation effect, with the caveat that the
Groups 3 Days interaction for sessions 7 and 8 did not
quite reach significance. The reason for this may have
been because the mean target search performance of
sessions 1 through 6 masks day-to-day variability in
the learning of each session’s new location by individual
animals and their memory of it the next day. As it is not
possible to evaluate reconsolidation in an individual an-
imal that performed poorly on session 7 just prior to drug
treatment (even if that same animal did well on previous
days), we considered only the subset of rats that reached
a threshold of session 7 search time at least twice the
chance level (i.e., >8% searching in the target zone).
This reduced the numbers of animals assessed (from
19 to 14) and revealed a significant Group 3 Days inter-
action for sessions 7 and 8 (F = 4.94, df 1/12, p < 0.05;
Figure 4B). The group mean consequently shows higher
values of time spent searching the target on session 7
(16.5%) but shows chance performance again on session
8 by the anisomycin group. This legitimizes the selection
of animals and argues against it having caused a mere re-
gression to the mean. In addition, if the zone measure is
calculated in a different way, looking only at the propor-
tion of time spent in each of the six zones used through-
out training, the Groups3Days interaction for days 7 and
8 remains significant (F = 5.79, df 1/13, p < 0.05; denom-
inator df increases by 1 as an additional anisomycin an-
imal could then be included). In absolute terms, the mean
search time in the target zone for the anisomycin group
dropped from 43.0% to 17.2% between days 7 and 8.
Given this apparent ‘‘reconsolidation’’ effect, it would
have been desirable to assay whether the poor memory
of the anisomycin group on session 8 was transient
Neuron
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days. Unfortunately, the DMP protocol does not lend
itself to such an analysis as, over time, all animals revert
to searching all over the pool as they have been trained
to do with the daily relocation of the platform.
Anisomycin Infusion without Memory Reactivation
HasNoEffect on 1DaySpatial Memory—Experiment 5
This control study used the same subset of 14 animals of
experiment 4 that had shown good memory retrieval on
day 7 of experiment 5. After an interval of 10 days, these
animals were retrained on the DMP task for 3 days, given
aCSF or anisomycin the next day without memory being
reactivated, and then a probe trial on session 5 (Figure 1).
No differences between groups were found over days 1
through 3 (F < 1) or on day 5 (F < 1; Figure 4C).
Extinction of Spatial Reference Memory Is
Unaffected by Anisomycin—Experiment 6
Figure 5 shows performance in the daily probe tests for
the extinction experiment. The groups did not differ dur-
ing the 6 days of training or during extinction (Fs < 1). A
high proportion of time was spent searching in the target
quadrant on the first memory retrieval trial of session 7
(52.5% 6 4.1% averaged across groups). This declined
across the eight repeated unrewarded probe trials of
extinction (probe tests 7 through 14; F = 8.82, df 7/70,
p < 0.001). Infusion of anisomycin or aCSF immediately
after these multiple extinction trials had no differential
impact upon performance the next day. Target search
was much lower for both groups in retrieval test 15 (ses-
sion 8; mean = 34.9%6 2.7% averaged across groups),
although still above chance (t = 3.65, df 11, p < 0.005).
During a further memory retrieval trial conducted 6
days later (test 16), no spontaneous recovery was seen
for either group (mean across groups = 25.2% 6 3.4%;
F = 1.39, df 1/11, p > 0.10), although there was a nonsig-
nificant trend for the group given anisomycin earlier to
perform slightly better (Groups 3 Tests interaction, F =
2.07, df 1/10, p > 0.10).
When the findings of experiments 2 and 6 were com-
pared, we observed that the overall level of performance
on session 9 was significantly higher after one trial of
memory ‘‘reactivation’’ than after eight trials of ‘‘extinc-
tion’’ (F = 10.47, df 1/36, p < 0.005), with no difference be-
tween groups across the two studies (F = 1.18, df 1/36,
p > 0.10). Thus, eight trials of extinction did cause
a greater decrease in spatial memory than a single
‘‘reactivation/extinction’’ trial. However, extinction was
unaffected by anisomycin.
Discussion
The key new finding is that the sensitivity of reactivated
spatial memory in the water maze to local inhibition of
protein synthesis in dorsal hippocampus is a function
of the kind of spatial memory task that has been trained.
In separate groups of animals all given an equivalent ex-
tent of training over 6 days, reactivation of a spatial
memory acquired in four trials in the immediately pre-
ceding session (DMP task) was sensitive to anisomycin
when tested the next day, whereas a memory that had
been acquired over the full 6 days was not. The dif-
ference cannot just have been a matter of memory‘‘updating,’’ as post-trial anisomycin in the DMP task
returned performance to chance levels. No significant
effect of anisomycin on allocentric spatial memory
was detected in the absence of memory reactivation in
either task. Key control studies revealed that the four
trials/day protocol used in experiments 2 and 5 was sen-
sitive to anisomycin, that extinction of spatial memory
was unaffected, and that the uptake and incorporation
of [14C]L-leucine following intrahippocampal infusions
of anisomycin revealed regionally localized inhibition of
protein synthesis in the hippocampus. This reversible
inhibition did not impair the ability of the treated animals
to learn a second water maze task in a different room
later.
The central theoretical issue that these data raise is
whether they support or argue against a process of
‘‘memory reconsolidation’’ with respect to spatial mem-
ory. We shall argue that these data are consistent with
the reconsolidation hypothesis, but at the same time
constrain the conditions under which the reconsolida-
tion of spatial memory takes place. Specifically, they
suggest that the engagement of a memory-encoding
mode during the act of spatial memory retrieval may
be one requirement for reconsolidation to be observed.
This occurs in spatial tasks when animals are confronted
by spatial novelty or ‘‘mismatch’’ that triggers explora-
tion and the updating of their cognitive representation
of space (O’Keefe and Nadel, 1978).
The Value and Limitations of Local Anisomycin
Infusion
Some recent experiments on reconsolidation have used
microinfusions of anisomycin into targeted brain areas
(Debiec et al., 2002; Eisenberg et al., 2003; Nader et al.,
2000; Runyan and Dash, 2005), whereas others have
used peripheral injections of this and other less-specific
Figure 5. Extinction of Spatial Reference Memory—Experiment 6
Time spent in the target quadrant during training, and the subse-
quent extinction trials, memory test, and 1 week test probe trials.
The drug infusions occurred immediately after the single session
in which extinction trials 7–14 were scheduled. Both groups showed
extinction of spatial memory in the retrieval test (session 15) relative
to that shown in session 7 (both are first trials of the day) and com-
pared to retrieval test 8 of experiment 2 above. There was no spon-
taneous recovery of spatial memory shown during the 1 week test.
Means 6 1 SEM.
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485drugs (Anokhin et al., 2002; Litvin and Anokhin, 2000; Su-
zuki et al., 2004; Taubenfeld et al., 2001). Peripheral ad-
ministration has the merit of being neutral regarding
the cerebral localization of the putative reconsolidation
process, but the twin disadvantages of precluding the
identification of the main target of action and potentially
increasing the likelihood of unwanted effects on physiol-
ogy and behavior (e.g., the transient sickness that often
accompanies systemic injections of anisomycin).
Central administration of drugs overcomes these
problems but is not without its own difficulties—includ-
ing potential tissue damage and an uneven diffusion
through the target brain area. One potential artifact to
consider was the possibility that infusions of anisomycin
cause permanent damage in the hippocampus and that
this, rather than direct effects of the drug, impairs spatial
performance. However, not only can this not explain the
differential outcome of experiments 2 and 4 (which both
had a single infusion), but also our ratings of the extent
of brain damage indicate that any infusion-associated
damage was both minimal and equivalent in the two
studies. Moreover, multiple infusions of anisomycin in
experiment 1 did not prevent subsequent learning of
a second water maze in the drug-free state.
A separate issue is that local infusion may affect only
one or a subset of the brain areas that subserve a neuro-
nal process, an issue that is analytically complicated, as
one area may be important during encoding and initial
storage (e.g., the hippocampus) with others being more
important for certain types of consolidation (e.g., se-
lected regions of the neocortex). These are potential
shortcomings of our experiments, but, overall, we con-
sider local drug administration to be more informative
than systemic administration in the long run. Our autora-
diographic observations revealed protein synthesis inhi-
bition to be very substantial, but it did not extend the full
length of the longitudinal axis of the hippocampus. The
more posterior and ventral regions were unaffected.
Given that learning occurred while the animals were un-
treated, resulting in the likely potentiation of a sparse
network of synapses throughout the entire hippocampus
(Moser and Moser, 1998b), it is possible that sufficient
protein synthesis could take place in the unaffected re-
gions to enable reconsolidation to occur normally. How-
ever, there are three reasons to question this criticism.
First, if sufficient protein synthesis is possible in the ven-
tral hippocampus to enable reconsolidation in experi-
ment 2, it should also have been sufficient to enable
consolidation in experiment 1. Second, the DMP task is
exquisitely sensitive to lesions of the dorsal hippocam-
pus, suggesting it to be the likely site of initial memory
trace formation within the hippocampus (de Hoz et al.,
2005). Third, lesion studies reveal that when damage oc-
curs after learning, lesions of as little as 30% of hippo-
campal volume are sufficient to limit subsequent mem-
ory retrieval (Moser and Moser, 1998a), whereas the
same small lesions may have a lesser effect when given
before training. This is presumably due to the dispersed
nature of the sparse representation of the spatial infor-
mation acquired by a normal brain when learning the
task. It seems parsimonious to assert that similar con-
straints should apply to other post-training treatments
(lesions and drugs) that may affect memory consolida-
tion and reconsolidation.Theoretical Implications: A Dual Encoding
and Retrieval State Is Required for Reconsolidation
of Spatial Memory
The reconsolidation hypothesis postulates that items in
long-term memory undergo new cycles of consolidation
upon their reactivation (Misanin et al., 1968; Nader, 2003;
Przybyslawski and Sara, 1997). This need not imply that
each consolidation cycle is mechanistically identical
to the preceding or subsequent consolidation cycles
(Bahar et al., 2004; Lee et al., 2004; Taubenfeld et al.,
2001; Tronel et al., 2005; von Hertzen and Giese, 2005),
but still, the reactivated memory is assumed to become
transiently unstable and, as during learning, prone to
disruption by at least some amnesic agents. Data in
line with the reconsolidation hypothesis have been ac-
cumulated over the years in many systems involving
multiple species and learning paradigms (Dudai, 2004;
Nader, 2003; Sara, 2000a).
At first sight, our findings seem to extend the general-
ity of the reconsolidation phenomenon to rapidly but
not slowly acquired forms of allocentric spatial memory,
echoing findings on reconsolidation of hippocampal-de-
pendent tasks in studies using peripheral injections of
anisomysin (Suzuki et al., 2004). This also parallels the
presence of hippocampal-dependent reconsolidation
following the retrieval of context fear conditioning that
is also learned in 1 day (Debiec et al., 2002). However,
with longer training that is subject to a hippocampally
localized protein synthesis-dependent consolidation
process (as shown in experiment 1), retrieval no longer
seems to engage a protein synthesis-dependent mech-
anism in the dorsal hippocampus (experiment 2). Re-
testing memory 7 days later also fails to reveal any effect
of anisomycin that might have been masked in the first
test. In contrast, if animals are required to learn a new lo-
cation each day, they can retain new spatial information
overnight, but the retrieval of such a memory continues
to reactivate a protein synthesis-dependent consolida-
tion-like process (experiment 5). Reconsolidation may
therefore occur in relation to rapidly acquired spatial
memory, with extent of training of a specific location be-
ing a key parameter. However, ‘‘extent of training’’ is
merely an operational description, and it would be better
to understand why this parameter influences the en-
gagement of reconsolidation.
The difference between the memory processes chal-
lenged in experiments 2 and 5, respectively, provides
a clue to the nature of this condition. Recent data have
provided evidence for ideas such as the behavioral dom-
inance of the memory trace and the balance between
extinction and nonextinction (Eisenberg et al., 2003;
Pedreira and Maldonado, 2003), the strength of the orig-
inal memory (Suzuki et al., 2004), and its age (Eisenberg
and Dudai, 2004; Litvin and Anokhin, 2000; Milekic and
Alberini, 2002) as factors influencing the likely engage-
ment of reconsolidation. The delayed matching-to-place
(DMP) task (Steele and Morris, 1999) points to another
possibility related to its simultaneous demands for both
retrieval and new encoding. This analytically powerful
task is sometimes incorrectly categorized as ‘‘working
memory,’’ but it is really one in which parts of an animal’s
experience are stable over time (e.g., that escape is pos-
sible) while other parts are not (e.g.,where it is possible).
Lower absolute levels of performance are typically
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even when extent of training is matched as here, because
the protocol is such that in recalling on day N + 1 where
the platform was on day N, the animal finds that the es-
cape platform has moved (or on a probe trial is absent).
Thus, over the training period, trial 1 involved both the re-
trieval of where the platform was in the previous session
and the immediate opportunity to encode, store, and
consolidate a new platform location. Engaging each of
these processes during the 6 days of DMP training would
then be likely to extend to include the memory retrieval
trial of session 7 conducted 72 hr later. Session 7 was
a nonrewarded probe trial, but the cognitive acts of
retrieval, platform searching, attending to extramaze
cues, and even failing to find the platform are likely to
engage memory-encoding processes, just as they do
during training. That it is nominally an ‘‘extinction’’ trial
is no reason to assume that new encoding could not
occur (Berman et al., 2003).
The hippocampus has been proposed to honor the
distinction between memory encoding and retrieval, by
sometimes rapidly recruiting different neuronal mecha-
nisms at different phases of the theta cycle (Hasselmo
et al., 2002). These differential activity configurations
could render the circuit differentially sensitive to amne-
sic agents, with the engagement of an encoding phase
favoring a plastic, transiently unstable state in the coher-
ently activated network that encodes the representa-
tion. It is noteworthy that mismatch between expected
and actual events in a retrieval session can trigger mem-
ory extinction or reconsolidation of contextual fear con-
ditioning in the crab Chasmagnathus (Pedreira et al.,
2004). Such mismatch is expected to drive encoding
(Rescorla and Wagner, 1972). Similarly, exposure to
a novel context together with a learned stimulus from
a different trained context will trigger second-order con-
ditioning whose consolidation and reconsolidation are
sensitive to anisomycin (Tronel et al., 2005).
Alternative Accounts
An alternative way of conceptualizing our findings might
be to suppose that the rat is engaged in no more than
ongoing learning and/or updating of what it has re-
trieved (Dudai and Eisenberg, 2004). If so, what would
be affected by the protein synthesis inhibitor after re-
trieval on day 7 is the consolidation of memory updating,
a proposal that fits within the conceptual framework
of the classical consolidation hypothesis and may not
require an explicit reconsolidation process (Rodriguez-
Ortiz et al., 2005). However, our data argue against this
parsimonious interpretation. As can be seen in Figures
4A and 4B, inhibition of protein synthesis returns the
performance to the pretraining chance level, a finding
difficult to reconcile with disruption of memory updating
only. We therefore suggest that the memory reactivation
session somehow induces protein synthesis-dependent
plasticity in the original trace and not only in its updated
portions. In other words, the engagement of a memory-
encoding state during reactivation triggers reconsolida-
tion or is at least a necessary condition for its occur-
rence.
A separate issue is that session 7 of experiment 5 is an
extinction trial. Experiment 6 was therefore important,
as it established that a hippocampal-dependent proteinsynthesis-dependent process is not directly engaged by
extinction of the spatial reference memory task despite
the consolidation of this task during acquisition being
dependent on protein synthesis. It is therefore unlikely
that the sensitivity of memory reactivation in the DMP
task to anisomycin has to do with extinction. Indeed,
to the contrary, the postsession application of anisomy-
cin decreased the performance seen on session 8 rather
than protected it. That the extinction of water maze spa-
tial reference memory can be sensitive to peripheral in-
jections of anisomycin (Suzuki et al., 2004) raises the
possibility that its long-lasting memory traces are actu-
ally in cortex rather than hippocampus, a view compat-
ible with the concept of systems-level consolidation.
One could argue that there is a confounding factor
across the two spatial tasks between relative memory
strength (Suzuki et al., 2004) and the requirement for
new encoding (the view expressed here). The spatial
memory developed over 6 days of the reference memory
task is quite strong and directs highly localized spatial
search, whereas that following 6 days of the DMP task
reflects only the learning that has occurred in the previ-
ous session. We recognize this inescapable constraint
on the experimental design but felt that matching the
numbers of days and trials of training across the two dis-
tinct tasks was vital. Further work might investigate the
impact of anisomycin on retrieval after 24 trials of refer-
ence memory training given within a single session or in-
creasing the numbers of trials per day of the DMP task
relative to the reference memory task. Even if the ani-
mals reach some asymptote of low escape latency and
optimal search during a single session of the reference
memory task, there is no guarantee that new memory
encoding will not be engaged on session 2. This is be-
cause systems-level consolidation is a time-dependent
process that cannot be short-circuited by extended
training in 1 day. However, even with extended training,
we predict that retrieval in the DMP task would remain
sensitive to protein synthesis inhibition irrespective of
the number of trials of training given each day or its de-
pendent consequence, memory strength, because the
dual retrieval/encoding mode would be automatically
engaged. It would also be valuable to investigate whether
reactivation of spatial memory in the DMP task engages
the synthesis of C/EBPb and, like Tronel et al. (2005),
use this to dissociate the relative contributions of con-
solidation and reconsolidation.
To summarize, our findings point to a differential con-
tribution of hippocampal protein synthesis to the con-
solidation, reconsolidation, and extinction of spatial
reference memory in a water maze. They suggest that
postretrieval sensitivity to protein synthesis inhibition
can be observed in circumstances that favor a new en-
coding mode during memory reactivation. Memory en-
coding is therefore proposed as a further boundary con-
dition on reconsolidation.
Experimental Procedures
Subjects
The data from a total of 86 experimentally naive male Lister Hooded
rats were used. The animals were housed individually in plastic
cages with ad libitum access to food and water. A 12 hr light/dark
cycle was maintained, with all the testing carried out in the light
phase (7 am to 7 pm). The series of studies were run in replicates,
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anced number of rats treated with aCSF or anisomycin.
Apparatus
Spatial training was conducted using two water mazes (Morris, 1981,
1984), each consisting of a large circular tank (2.0 min diameter) of
water (depth, 0.6 m; temperature, 25ºC 6 1ºC) made opaque by the
addition of 150 ml of latex solution. Each water maze was located in
a separate room (upstairs pool, downstairs pool) distinguished by
their extramaze cues. A 12 cm diameter Atlantis Platform (Spooner
et al., 1994) was hidden at a fixed location in each water maze. This
platform is initially submerged such that its top surface is >30 cm be-
low the surface and then is raised automatically and at an appropriate
time to its normal position of 1.5 cm below the water. This enables (1)
the selective reinforcement of swimming to and dwelling at the cor-
rect location in the pool during training through the use of suitable an-
imal tracking software; and (2) rewarded probe tests to be scheduled
on trial 1 of each training day by allowing the rat to escape onto the
now raised platform after a 60 s swim. The animals’ swimming behav-
ior was monitored by an overhead video camera, a video recorder,
and a commercially available online data acquisition system that
used video frame-grabbing software (Watermaze Software, Edin-
burgh, UK) that digitizes the path taken and computes various pa-
rameters. This allowed the collection of objective measures of the
paths taken by the rats as they searched for the platform (e.g., la-
tency, path length, swim speed, time in quadrant of the pool, or
zone around platform, etc.) from which it is possible to make infer-
ences about their knowledge of its spatial location. A separate com-
puter-based image analysis system (MCID, Ontario, Canada) was
used for autoradiographic analysis of protein synthesis inhibition.
Behavioral Protocols
The primary aim was to examine, successively, the impact of intra-
hippocampal anisomycin infusions upon the acquisition/consolida-
tionof spatial reference memory acquired over 6 days (experiment 1),
the reconsolidation of such memory when it was reactivated 72 hr
after training (experiment 2), and upon memory after nonreactiva-
tion (experiment 3). These were followed by the experiments using
the DMP paradigm to examine the impact of intrahippocampal
protein synthesis inhibition upon the reconsolidation of a spatial
memory that was retrieved 72 hr after having been acquired in 1
day (experiment 4) and upon subsequent memory after nonreactiva-
tion (experiment 5). Finally, the extinction of spatial memory was
studied after prior training in the reference memory protocol (exper-
iment 6). The series also included quantitative measurements of the
extent of inhibition of protein synthesis in the hippocampus.
Surgery
Bilateral guide cannulae for subsequent infusion of drugs (Plastic
One Inc, 26 gauge with stylets) were implanted bilaterally into the
dorsal hippocampus (AP, 24.5 mm; lateral, 63.0 mm; ventral, 3.0
mm from dura) under tribromoethanol (Avertin) anesthesia using
standard stereotaxic techniques. The cannulae were secured by
means of dental cement and small skull screws, and the animals
were allowed to recover for at least 14–21 days prior to the start of
all behavioral training.
Drugs and Infusions
Anisomycin was dissolved in equimolar HCl, diluted with aCSF and
adjusted to pH 7 with NaOH to produce a final concentration of ani-
somycin of 125 mg.ml21. The artificial cerebrospinal fluid (aCSF) was
made using pyrogen-free (injectable) water and consisted of NaCl
(150 mM), KCl (3 mM), CaCl2 (1.4 mM), MgCl2 (0.8 mM), Na2HPO4
(0.8 mM), and NaH2PO4 (0.2 mM). During post-training or post-mem-
ory retrieval drug infusions, the rats were restrained lightly in a towel
and drug or aCSF infused at a rate of 0.25 ml.min21 over 8 min. The
infusion cannulae (bilateral) were left in place for a further 2 min,
and the animal then returned to its home cage. The times when these
infusions were given are noted for each experiment below.
Cued Pretraining
Prior to starting any procedures in each experiment, all rats were
handled extensively and ‘‘habituated’’ to the water maze by giving
them a single 60 s swim trial in water maze 1 (WM1) with no escape
platform present. On the following day, the animals were given eighttrials of cued pretraining in WM1 (curtains were drawn around the
pool to occlude extramaze cues, hidden escape platform at four
separate locations in the pool, four start locations, Atlantis Platform
lowered at the start of each trial, rat had to swim for 1 s below a hang-
ing cue that indicated the platform position in order to raise it to a po-
sition near the surface that would afford escape from the water, max
trial duration = 120 s, 30 s on platform at the end of each trial). All
animals concluded this phase effectively, and, for clarity, the data
are not presented.
Spatial Training
All animals were then trained over 6 days to locate a hidden platform
in a fixed or varying location within WM1. The platform position was
counterbalanced (NE for half the animals, SW for the remainder) in
the reference memory experiments (experiments 1–3 and 6), but
occupied many different locations in the DMP experiments (experi-
ments 4 and 5). Except where noted, the Atlantis Platform either
came up automatically after 60 s on a probe test (trial 1 of each
day) or after the rats had swum for ‘‘dwell’’ periods of 1 to 2.5 s in
a zone whose dwell radius could be specified by the experimenter.
Training was for 6 days (four trials per day, max trial duration = 120 s,
Atlantis Platform on all trials, a probe test lasting 60 s on trial 1
throughout training with, thereafter, the platform raised only by local-
ized swimming, 30 s on the platform after each swim trial). The dwell
radius was set at 20 cm (Dwell times: day 1 = 1 s; day 2 = 1.5 s; day 3 =
2 s; days 4–6 = 2.5 s). Trial 1 of each day enabled the gradually devel-
oping memory for the platform location to be tested daily. As trial 1 of
each day was a rewarded probe test, the latency to the ‘‘first cross-
ing’’ of the platform’s position was used in analyses of time taken
to reach the platform’s location instead of escape latency.
Experiment 1: Consolidation of Spatial Reference Memory
The aim of the first ‘‘control’’ study (n = 15) was to confirm that bilat-
eral, intrahippocampal infusions of anisomycin (250 mg per hippo-
campus) would block the consolidation of long-term spatial memory.
To do this, either anisomycin (n = 7) or aCSF (n = 8) was infused im-
mediately (<5 min) after the end of each animal’s four trials of training
over sessions 1–6 of spatial training (as described above). A 60 s non-
rewarded probe test was conducted on session 7 (72 hr after session
6), without any post-testing drug infusions, and again on session 8
(24 hr after session 7). For probe test 7—the memory reactivation
trial—the animals were started from either the nominal adjacent-
left or adjacent-right quadrants of the pool (i.e., never the target or
opposite quadrants) and lifted out from the pool while swimming
when the 60 s swim period was completed without any opportunity
to climb onto the hidden platform. Training in WM1 was followed
by training in WM2 to check whether anisomycin infusion caused
any lasting functional disruption of the brain. No drug infusions
were given. One hour after completion of the probe test on session
8, animals were taken to WM2 to learn an escape location in a novel
environment. The rats were then trained for 4 days using a similar
protocol to that used in WM1. The dwell radius was set at 20 cm
(the dwell times were: day 1 = 1 s; day 2 = 1.5 s; day 3 = 2 s; days
4 = 2.5 s). Tests of the animals’ ability to retrieve a memory of the
location of the platform, or to extinguish the memory, were then con-
ducted 72 and 96 hr after completion of training (sessions 5 and 6).
Experiment 2: Reconsolidation of Spatial Reference Memory
The aim of this study (n = 29) was to examine whether bilateral, intra-
hippocampal infusions of anisomycin blocked reconsolidation of
long-term spatial memory. To do this, only aCSF was infused imme-
diately (<5 min) after the end of each animal’s four trials of training
over sessions 1–6 of spatial training (as described above). Memory
retrieval was then examined by means of 60 s nonrewarded probe
test on session 7, 72 hr after session 6. Half the animals were given
an immediate postretrieval infusion of anisomycin (n = 15) and the
other half given aCSF (n = 14). Start locations were as in experiment
1. A memory probe test was scheduled on day 8. On session 7, as in
experiment 1, the animals were lifted from the pool when the 60 s
swim period was completed, without any opportunity to climb
onto the hidden platform.
Experiment 3: Nonreactivation (i.e., Infusion-Only Control)
This study (n = 12) was identical to experiment 2 in every respect
except that exposure to the water maze on session 7 (memory
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were accepted after testing and blind histological assessment:
aCSF (n = 7), anisomycin (n = 5).
Experiment 4: Reconsolidation of 1 Day Memory
This study (n = 19) examined whether bilateral, intrahippocampal in-
fusions of anisomycin blocked reconsolidation of spatial memory
acquired in 1 day. As in experiments 2–4, aCSF was infused imme-
diately (<5 min) after the end of each animal’s four trials of training
over sessions 1–6 of spatial training. The key difference to experi-
ment 2 was that the hidden platform moved location between ses-
sions. Memory retrieval for the previous session’s training location
was examined throughout training by means of 60 s rewarded probe
test on trial 1. A single, nonrewarded memory retrieval trial was given
on session 7, at the same 72 hr interval after session 6, followed by
an immediate infusion of anisomycin (n = 9) or aCSF (n = 10). A mem-
ory probe test was scheduled on day 8.
Experiment 5: Nonreactivation of 1 Day Memory (i.e., Drug
Infusions Only)
This study (n = 14) used the same subset of the animals in experi-
ment 5 that had shown good retention on day 7 of that task. After
a 10 day delay, these animals were retrained on the DMP task for
three sessions, then given aCSF (n = 9) or anisomycin (n = 5) infu-
sions on session 4 without exposure to the water maze (i.e., no mem-
ory reactivation). A memory retrieval test was given as session 5.
As in experiment 3 above, the aim was to examine whether bilateral,
intrahippocampal infusions of anisomycin had nonspecific effects
on spatial memory unconnected with reconsolidation.
Experiment 6: Extinction of Spatial Reference Memory
This study (n = 12) examined whether bilateral, intrahippocampal in-
fusions of anisomycin blocked the extinction of long-term spatial
memory. Initial training was as in experiment 2. The key difference
was that a series of eight successive extinction trials were scheduled
on session 7, beginning 72 hr after session 6, followed by an immedi-
ate infusion of anisomycin (n = 5) or aCSF (n = 7). These eight extinc-
tion trials lasted for 60 s each. They all started from the adjacent-left
and adjacent-right quadrants of the pool in semirandom sequence
and terminated with the animals being lifted from the pool. A further
memory probe test was scheduled on session 8, and 6 days later, on
session 9.
Protein Synthesis Inhibition
A semiquantitative assay of de novo protein synthesis in the brain
(Smith, 1991) was conducted using a subset of six animals that
had previously been trained behaviorally (the aCSF animals of ex-
periment 4). To enable each animal to serve as its own control,
one hippocampus was infused with anisomycin and the other, simul-
taneously, with aCSF. Otherwise, the injection protocol followed ex-
actly the procedure of the behavioral experiments. Twenty minutes
following the end of the intracerebral injections, a bolus of [14C]L-
leucine (Amersham Biotech; specific activity 59 mCi.mmol21) was
injected into the tail vein (7.5 mCi.100 g21) and the animals returned
to their home cage for the subsequent 60 min. At the end of this pe-
riod, the animals were decapitated and trunk blood collected into
heparinized centrifuge tubes. The brains were dissected intact and
rapidly frozen in precooled 2-methylbutane (245ºC). Frozen brains
were mounted onto specimen holders with embedding medium (Lip-
shaw) and stored overnight at 280ºC. Whole-blood samples were
centrifuged (13,000 3 g for 60 s), and 20 ml aliquots of plasma
were taken for liquid scintillation analysis to determine blood con-
centrations of tracer at the end of the experiment.
The brains were sectioned (20 mm) in the coronal plane using
a cryostat maintained at 222ºC. Three consecutive sections from
every 100 mm cut throughout the rostro-caudal axis of the hippo-
campus were thaw mounted onto a glass coverslip and rapidly dried
on a hot plate (75ºC). In areas of the brain more rostral and caudal to
hippocampus, three sections were collected from every 400 mm of
tissue sectioned. Autoradiograms were prepared by applying these
sections, together with a series of eight precalibrated [14C]-stan-
dards (40–1069 nCi/g tissue equivalents: Amersham Biotech, UK),
to X-ray film (Kodak, SB-5) in light-tight cassettes for 7 days. At
the end of the exposure time, the films were processed according
to the manufacturer’s instructions. Sections adjacent to thoseused for autoradiography were mounted onto gelatine-coated slides
and stained with cresyl violet.
Analysis of the autoradiograms was performed using a computer-
based image analysis system (MCID/M5+). The background density
of the films was measured, and local tissue isotope concentrations
were derived from the optical density of autoradiographic brain im-
ages, following background subtraction, relative to the [14C]-stan-
dards. Measurements of tracer levels in hippocampal subfields
were taken from three sets of consecutive sections at the level of
the habenula (bregma23.30 mm approx.) and at the level of the me-
dial geniculate (bregma 25.80 mm approx.). Thus for each subfield
at each level, tracer levels were derived from the mean of nine mea-
surements for each side of the brain separately. To determine the
concentrations of tracer found in the hippocampus as a whole, the
outline of the structure was delineated using cresyl violet sections,
the area stored on the computer, and then superimposed upon the
adjacent autoradiographic images.
Histology
At the end of the experiments, all rats were deeply anesthetised, and
their brains were removed and postfixed in 10% formalin. They were
sectioned in the coronal plane throughout the region of the cannula
placements (40 mm sections) and stained with cresyl violet. The sec-
tions were assessed ‘‘blind’’ with respect to the behavioral data by at
least two observers (J.I., J.A.A., and R.G.M.M.); rats included in the
statistical analysis had to have (1) the cannulae terminating in the
dorsal hippocampus bilaterally; and (2) a maximum of slight unilateral
tissue damage at the termination site. The histological ratings were
conducted quantitatively with ratings given as follows: 0 = no brain
damage other than that inevitably caused by the cannulae; 1 = mini-
mal damage to the hippocampus at the cannulae tips; 2 = infusion-
associated but strictly unilateral hippocampal damage; 3 = extensive
unilateral and minor contralatral hippocampal damage; 4 = exten-
sive bilateral damage associated with infusions of aCSF or anisomy-
cin. Animals were only included in the study with scores of 2 or less.
Data Analysis
All data were analyzed using ANOVA, with group sizes determined
after the blind histological assessment. Conventional measures of
performance in water maze experiments include escape latency,
path length, and swim speed during training, and percent quadrant
or target zone occupancy during post-training probe tests. Here, our
use of the Atlantis Platform to encourage focused searching in the
correct target location necessitated different measures of perfor-
mance during training and memory probe trials. On training trials,
the platform would not rise if a rat swam accurately to the target
area but stayed there for a slightly shorter period than that session’s
required dwell time. Typically, the animal returns to the correct area
and then remains long enough to activate raising of the platform.
First crossing latency is then a more appropriate measure than over-
all escape latency. Swim speeds did not differ across groups that
always received their drug infusions after behavioral testing, and
path length was not then used, as it tends to show slightly greater
variability than latency scores due to occasional tracking errors.
Thus, the three main measures of performance used were (1) first
crossing latency (s) during training; (2) percent time spent swimming
in the target quadrant during reference memory retrieval tests; and
(3) percent time spent swimming in a target zone during DMP probe
tests. The retrieval tests were always on the first trial of each session
and, as described above, involved the hidden platform being raised
to within 1.5 cm of the water surface only after 60 s had passed.
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